Showing posts with label
Medicine
.
Show all posts
Showing posts with label
Medicine
.
Show all posts
Monday, January 12, 2026
Why we own BEAM Therapeutics - update January 2026
›
Beam Therapeutics (NASDAQ: BEAM) Updated Investment & Business Report – January 2026 Theme: Precision genetic medicine through base...
Tuesday, December 23, 2025
I believe Cabaletta Bio (NASDAQ: CABA) is a microcap with a serious chance at success. Maybe even a takeover target!
›
Cabaletta Bio (NASDAQ: CABA) Retail Investor Investment/Business Report for 2026–2029 With Model Buyout Scenarios and Valuation Ranges ...
Thursday, August 28, 2025
BEAM Therapeutics - A simplified investor report!
›
Beam Therapeutics (NASDAQ: BEAM) Simplified Investor Report – August 2025 1. What Beam Does Beam is a gene-editing company that uses ...
Tuesday, May 27, 2025
Cabaletta Bio (CABA) is a microcap stock with a serious pipeline in the Healthcare field, and a possible takeover target. Read on...
›
Cabaletta Bio Might See a Takeover Offer in the Near Future Date: May 27, 2025 Ticker: NASDAQ: CABA Sector: Biotechnology Market Ca...
Tuesday, April 1, 2025
BEAM Therapeutics getting closer to FDA approvals for cutting edge therapies
›
Beam Therapeutics Inc. (NASDAQ: BEAM) is a biotechnology company specializing in precision genetic medicines through its proprietary base ...
›
Home
View web version
